바이오정보모아 (BioJungboMoa) — ADC · Antibody

8428프로그램 40FDA 승인

1,732오늘 방문

8,766누적 방문

7303갱신 대기 S–CData Tier S/A/B차세대 →Insight 1032HER2 breast 4683Antibody 2713CGT →Psoriasis →NSCLC 40FDA 승인

피드 Data Tier 차세대 Insight

T-cell receptor (TCR, T-cell receptor, T-cell receptor (TCR) repertoire)

COVID-19 · COVID-19

#COVID-19#CGT#Preclinical#세포유전치료#CAR-T+2

효능 ORR 67%임상시험 1상태 ACTIVE

ADCBiologicstaleFudan UniversityPhase 2

C1: SHR-A1811 (C1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

CGTBiologicstaleErasmus Medical CenterPhase 2

Adoptive therapy with autologous MC2 TCR T cells (Adoptive therapy with autologous MC2 TCR T cells)

Melanoma; Melanoma, Uveal · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

CGTBiologicstaleArtielle ImmunoTherapeuticsPhase 1

recombinant T cell receptor ligand (RTL1000, RTL1000 (recombinant T cell receptor ligand))

Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Chronic Progressive

#MultipleSclerosisChronicProgress#CGT#Phase1#세포유전치료#CAR-T+4

효능 ORR 2%임상시험 1상태 ACTIVE

CGTBiologicstaleFred Hutchinson Cancer CenterPhase 1

ROR1 CAR-specific Autologous T-Lymphocytes (ROR1 CAR-specific Autologous T-Lymphocytes)

Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

효능 ORR 0%임상시험 1상태 DISCONTINUED

ADCBiologicstaleShanghai Henlius BiotechPhase 3

HLX87+HX22 (HLX87+HX22)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

ADCBiologicstaleFudan UniversityPhase 2

B2: TROP2 ADC with Camrelizumab (B2: TROP2 ADC with Camrelizumab)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

ADCBiologicstaleSun Yat-Sen Memorial Hospital o…Phase 3

Fluorizoparib (Fluorizoparib)

Metastatic Breast Cancer; HRD-Positive/HER2-Negative Advanced Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4

임상시험 1상태 RECRUITING

AntibodystaleRochePhase 3

Triamcinolone Acetonide and Bevacizumab (Triamcinolone Acetonide and Bevacizumab)

Diffuse Diabetic Macular Edema · Diffuse Diabetic Macular Edema

#DiffuseDiabeticMacularEdema#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 DISCONTINUED

ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYS6010 jnjection (SYS6010 jnjection)

Advanced Solid Tumors; Breast Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

ADCBiologicstaleConjupro Biotherapeutics, Inc.Phase 1

CPO301 (CPO301)

Cancer; Cancer, Lung · Cancer

#Cancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

ADCBiologicstaleTORL Biotherapeutics, LLCPhase 1

TORL-4-500 (TORL-4-500)

Advanced Solid Tumor; Hepatocellular Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

CGTBiologicstaleUniversity College, LondonPhase 1

CMV-TCR transduced donor-derived T cells (CMV-TCR transduced donor-derived T cells)

Haematological Malignancies; CMV Infection · Haematological Malignancies

#HaematologicalMalignancies#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

CGTBiologicstaleLion TCR Pte. Ltd.Phase 1

LioCyx-M, HBV antigen-specific TCR-redirected T cells (LioCyx-M, HBV antigen-specific TCR-redirected T cells)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

Tcrx T cell (Tcrx T cell)

Gastric Cancer; Gastroesophageal-junction Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

ADCBiologicstaleYonsei UniversityPhase 2

Trastzumab Deruxtecan (Trastzumab Deruxtecan)

Ovarian Cancer; Ovarian Carcinoma, Recurrent · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 1상태 RECRUITING

CGTBiologicstaleUniversity of PennsylvaniaPhase 1

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

Relapsed or Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

CGTBiologicstaleUniversity of Wisconsin, MadisonPhase 1

TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC, TCRαβ+/CD19+ depleted Hematopoietic stem cell, TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft)

Blood Disease · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 2

MB-dNPM1-TCR.1 (MB-dNPM1-TCR.1)

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 1상태 RECRUITING

AntibodystaleSWOG Cancer Research NetworkPreclinical

Rilotumumab (Rilotumumab)

Recurrent Squamous Cell Lung Carcinoma; Stage IV Squamous Cell Lung Carcinoma AJCC v7 · Recurrent Squamous Cell Lung Carcinoma

#RecurrentSquamousCellLungCarcino#Antibody#Preclinical#항체#면역항체+3

효능 ORR 21%임상시험 1상태 ACTIVE

CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

2G-1 TCR Retroviral Vector-Transduced lyn (2G-1 TCR Retroviral Vector-Transduced lyn)

Renal Cancer; Kidney Cancer · Renal Cancer

#RenalCancer#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

ADCBiologicstaleEisai Inc.Phase 2

BB-1701 (BB-1701)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 ACTIVE

CGTBiologicstaleWashington University School of…Phase 2

TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft (TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft)

AML, Childhood; Aml · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 1상태 RECRUITING

CGTBiologicstaleFred Hutchinson Cancer CenterPhase 1

Autologous Mesothelin-specific TCR-T Cells (Autologous Mesothelin-specific TCR-T Cells)

Metastatic Pancreatic Ductal Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8 · Metastatic Pancreatic Ductal Adenocarcin

#MetastaticPancreaticDuctalAdenoc#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

CGTBiologicstaleShanghai Pudong HospitalPhase 1

IX001 TCR-T cells (IX001 TCR-T cells)

Pancreatic Cancer; Colorectal Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

66 / 142 페이지

← 이전 다음 →

전체 8,428개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 1,732 / 8,766

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

T-cell receptor (TCR, T-cell receptor, T-cell receptor (TCR) repertoire)

C1: SHR-A1811 (C1: SHR-A1811)

Adoptive therapy with autologous MC2 TCR T cells (Adoptive therapy with autologous MC2 TCR T cells)

recombinant T cell receptor ligand (RTL1000, RTL1000 (recombinant T cell receptor ligand))

ROR1 CAR-specific Autologous T-Lymphocytes (ROR1 CAR-specific Autologous T-Lymphocytes)

HLX87+HX22 (HLX87+HX22)

B2: TROP2 ADC with Camrelizumab (B2: TROP2 ADC with Camrelizumab)

Fluorizoparib (Fluorizoparib)

Triamcinolone Acetonide and Bevacizumab (Triamcinolone Acetonide and Bevacizumab)

SYS6010 jnjection (SYS6010 jnjection)

CPO301 (CPO301)

TORL-4-500 (TORL-4-500)

CMV-TCR transduced donor-derived T cells (CMV-TCR transduced donor-derived T cells)

LioCyx-M, HBV antigen-specific TCR-redirected T cells (LioCyx-M, HBV antigen-specific TCR-redirected T cells)

Tcrx T cell (Tcrx T cell)

Trastzumab Deruxtecan (Trastzumab Deruxtecan)

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC, TCRαβ+/CD19+ depleted Hematopoietic stem cell, TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft)

MB-dNPM1-TCR.1 (MB-dNPM1-TCR.1)

Rilotumumab (Rilotumumab)

2G-1 TCR Retroviral Vector-Transduced lyn (2G-1 TCR Retroviral Vector-Transduced lyn)

BB-1701 (BB-1701)

TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft (TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft)

Autologous Mesothelin-specific TCR-T Cells (Autologous Mesothelin-specific TCR-T Cells)

IX001 TCR-T cells (IX001 TCR-T cells)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

T-cell receptor (TCR, T-cell receptor, T-cell receptor (TCR) repertoire)

C1: SHR-A1811 (C1: SHR-A1811)

Adoptive therapy with autologous MC2 TCR T cells (Adoptive therapy with autologous MC2 TCR T cells)

recombinant T cell receptor ligand (RTL1000, RTL1000 (recombinant T cell receptor ligand))

ROR1 CAR-specific Autologous T-Lymphocytes (ROR1 CAR-specific Autologous T-Lymphocytes)

HLX87+HX22 (HLX87+HX22)

B2: TROP2 ADC with Camrelizumab (B2: TROP2 ADC with Camrelizumab)

Fluorizoparib (Fluorizoparib)

Triamcinolone Acetonide and Bevacizumab (Triamcinolone Acetonide and Bevacizumab)

SYS6010 jnjection (SYS6010 jnjection)

CPO301 (CPO301)

TORL-4-500 (TORL-4-500)

CMV-TCR transduced donor-derived T cells (CMV-TCR transduced donor-derived T cells)

LioCyx-M, HBV antigen-specific TCR-redirected T cells (LioCyx-M, HBV antigen-specific TCR-redirected T cells)

Tcrx T cell (Tcrx T cell)

Trastzumab Deruxtecan (Trastzumab Deruxtecan)

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC, TCRαβ+/CD19+ depleted Hematopoietic stem cell, TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft)

MB-dNPM1-TCR.1 (MB-dNPM1-TCR.1)

Rilotumumab (Rilotumumab)

2G-1 TCR Retroviral Vector-Transduced lyn (2G-1 TCR Retroviral Vector-Transduced lyn)

BB-1701 (BB-1701)

TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft (TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft)

Autologous Mesothelin-specific TCR-T Cells (Autologous Mesothelin-specific TCR-T Cells)

IX001 TCR-T cells (IX001 TCR-T cells)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

T-cell receptor (TCR, T-cell receptor, T-cell receptor (TCR) repertoire)

C1: SHR-A1811 (C1: SHR-A1811)

Adoptive therapy with autologous MC2 TCR T cells (Adoptive therapy with autologous MC2 TCR T cells)

recombinant T cell receptor ligand (RTL1000, RTL1000 (recombinant T cell receptor ligand))

ROR1 CAR-specific Autologous T-Lymphocytes (ROR1 CAR-specific Autologous T-Lymphocytes)

HLX87+HX22 (HLX87+HX22)

B2: TROP2 ADC with Camrelizumab (B2: TROP2 ADC with Camrelizumab)

Fluorizoparib (Fluorizoparib)

Triamcinolone Acetonide and Bevacizumab (Triamcinolone Acetonide and Bevacizumab)

SYS6010 jnjection (SYS6010 jnjection)

CPO301 (CPO301)

TORL-4-500 (TORL-4-500)

CMV-TCR transduced donor-derived T cells (CMV-TCR transduced donor-derived T cells)

LioCyx-M, HBV antigen-specific TCR-redirected T cells (LioCyx-M, HBV antigen-specific TCR-redirected T cells)

Tcrx T cell (Tcrx T cell)

Trastzumab Deruxtecan (Trastzumab Deruxtecan)

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC, TCRαβ+/CD19+ depleted Hematopoietic stem cell, TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft)

MB-dNPM1-TCR.1 (MB-dNPM1-TCR.1)